What happened Shares of R1 RCM (NASDAQ: RCM) had tumbled 12.6% as of 11:42 a.m. EDT on Tuesday. The decline came after the healthcare technology company announced its first-quarter results before the market opened. So what R1 RCM reported revenue of $342.6 million in the first quarter. That result topped the consensus analyst estimate of $339.2 million. However, the company's net loss of $2.37 per diluted share was a lot worse than its earnings of $0.05 per diluted share in the prior-year period. It also came in well below the average analyst estimate of a net loss of $0.03 per share. Image source: Getty Images. There's obviously a disconnect between what analysts projected for the first quarter and what the company anticipated. CFO Rachel Wilson said, "We are pleased to report another strong quarter, with results ahead of our expectations." While R1 RCM's first-quarter results were the main reason for the healthcare stock falling today, it didn't help that the overall stock market slid. This broader market pullback likely made the stock's decline worse than it would have otherwise been. Now what R1 RCM expects to deliver solid revenue growth for full-year 2021. The company projects revenue will be between $1.41 billion and $1.46 billion, with the midpoint of that range reflecting a year-over-year increase of 13%. 10 stocks we like better than R1 RCM Inc.When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and R1 RCM Inc. wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of February 24, 2021 Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.Source